Key Highlights
- JPMorgan elevated IBM to Overweight rating with a price objective of $291, increased from $270
- Shares climbed more than 4% to approximately $263, bucking broader market weakness
- Software operations represent ~45% of total revenue yet generate nearly two-thirds of overall earnings
- Trump issued two executive orders supporting quantum computing development, acknowledging IBM CEO Arvind Krishna
- Company committed $10 billion toward quantum research across five years; second-quarter results scheduled for July 22
International Business Machines experienced a powerful combination of positive developments on Tuesday, sending shares significantly higher.
International Business Machines Corporation, IBM
JPMorgan’s Brian Essex elevated his rating on IBM shares to Overweight from Neutral while simultaneously lifting his price objective to $291 from $270. The equity responded with gains exceeding 4%, reaching approximately $263.20, despite Nasdaq futures declining 2.66% and S&P 500 futures retreating 1.30%.
Essex’s investment thesis centers on a straightforward premise: IBM’s software segment serves as the profit powerhouse, with its significance continuing to expand. While software generates approximately 45% of overall revenue, it produces nearly two-thirds of consolidated earnings. As artificial intelligence adoption accelerates, Essex anticipates this favorable revenue composition will continue trending toward software dominance.
The technology giant has executed approximately 50 strategic acquisitions during the previous five years to advance this transformation, including the notable Confluent acquisition in March. While certain Wall Street observers have raised concerns about the acquisition velocity, Essex believes that aggressive software investments today will diminish future capital requirements while simultaneously transitioning the company toward predictable subscription-based revenue streams.
The analyst additionally highlighted potential valuation expansion opportunities should IBM establish itself as a credible AI infrastructure provider or expedite its quantum computing roadmap.
Presidential Support for Quantum Technology
The analyst upgrade represented only one positive catalyst. On Monday, President Trump authorized two executive orders focused on quantum technology advancement — one establishing a mandate to develop a research-grade quantum computer by 2028, with another accelerating government adoption of post-quantum cryptography by 2031.
IBM’s Chief Executive Arvind Krishna participated in the Oval Office signing ceremony. Trump subsequently expressed remorse about divesting his IBM holdings prematurely. Such high-profile presidential recognition provides meaningful reputational benefits.
IBM and the Commerce Department collectively announced a $1 billion commitment earlier this year to construct Anderon, an independent quantum foundry. Subsequently, IBM pledged an incremental $10 billion toward quantum research and production capabilities throughout the next five years.
Essex highlighted that IBM has already captured more than $1.1 billion in quantum computing customer agreements since 2017 and surpassed $1 billion in aggregate quantum-related revenue. He positions IBM favorably within what he characterizes as a “meaningful total addressable market” for quantum technologies.
The company’s internal objective targets delivery of its most advanced quantum system, Starling, by 2029. Essex indicated any acceleration of this timeline “could result in upside” for investors.
Analyst Community Perspectives
IBM has accumulated increasingly optimistic analyst coverage. Barclays launched coverage at Buy rating earlier this month establishing a $350 price objective, while Citigroup maintains a Buy rating with a $375 target. Wedbush assigns an Outperform rating with a $320 price target.
On Monday, IBM announced participation in OpenAI’s Daybreak Cyber Partner Program and unveiled a new AI-enhanced application security offering designed to help enterprises detect and remediate software vulnerabilities more efficiently.
The platform leverages OpenAI’s technology to analyze code, rank critical security gaps, and map exploitable attack vectors. This builds upon Project Lightwell, IBM’s $5 billion collaboration with Red Hat concentrating on software supply chain protection.
IBM releases second-quarter financial results on July 22. Analyst consensus anticipates earnings per share of $3.00, up from $2.80 in the comparable period, with revenue projected at $17.85 billion compared to $16.98 billion in the year-ago quarter.
